Navigation Links
Caliper Life Sciences' Second Quarter 2009 Financial Results Conference Call Notice
Date:7/16/2009

HOPKINTON, Mass., July 16 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) will conduct a conference call discussing the company's second quarter 2009 financial results at 9:00 a.m. ET on Thursday, July 30. Kevin Hrusovsky, President and Chief Executive Officer and Peter McAree, Chief Financial Officer, will host the call. Management will discuss operational and financial results and the company's outlook for the future.

A news release discussing Caliper's second quarter 2009 financial results will be issued Thursday, July 30 at approximately 7:00 a.m. ET.

Participants please call 888.713.4209 five to ten minutes prior to the call and use the participant passcode of 64195782. International callers can access the call by dialing 617.213.4863 and entering the same passcode. You may also pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=PB3C889QD.

A live webcast of the call can be accessed at www.fulldisclosure.com or on the Caliper website at www.caliperLS.com in the Events section of the Investor Relations page. A webcast replay of the call will remain available until Caliper's earnings call for the third quarter of 2009.

Telephone replays of the conference call will be available approximately two hours after the completion of the call. To access a telephone playback of the proceedings from July 30 through August 6, dial 888-286-8010 and use the participant passcode of 38849510. International callers can access the playback by dialing 617-801-6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis
2. Caliper Life Sciences to Webcast Investor Session of Open House
3. Caliper Life Sciences Reports First Quarter 2009 Results
4. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
5. EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort
6. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
7. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
8. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
9. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
10. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
11. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):